Literature DB >> 7051714

Increase of HLA haplotype A9-Bw16 in familial insulin-dependent diabetes mellitus in northern-Finland.

J Ilonen, H K Akerblom, A Tiilikainen, A Mustonen, E Herva, S Koskimies, K Kouvalainen.   

Abstract

Twenty-one families, each with two diabetic children, from North Finland were HLA typed. The grade of HLA identity between diabetic siblings was evaluated, and frequencies of various HLA antigens in familial cases were compared to those of non-familial cases from the same area. Ten pairs of diabetic children were HLA-identical and eleven haploidentical; two of the latter were identical for the HLA-D locus. These figures emphasize the significance of HLA-region associated genetic factors in the susceptibility to the disease, but do not support a simple dominant/recessive gene theory. There was a significant difference between familial and non-familial IDDM cases in the frequencies of B15, Bw16, B40 and Cw3 antigens. Bw16 was greatly increased and B15, B40 and Cw3 decreased among familial cases. The haplotype A9, Bw16 was common in familial cases, but, compared to healthy controls, the frequencies of the two antigens were also slightly increased among non-familial cases. Neither Dw3 nor Dw4 was associated with Bw16 antigen. The differences between familial and non-familial IDDM cases and the significance of the A9, Bw16 combination in the patients emphasize the heterogeneity of IDDM.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051714     DOI: 10.1007/bf02581153

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  8 in total

1.  Genetics of juvenile diabetes mellitus. A recessive gene closely linked to HLA D and with 50 per cent penetrance.

Authors:  P Rubinstein; N Suciu-Foca; J F Nicholson
Journal:  N Engl J Med       Date:  1977-11-10       Impact factor: 91.245

2.  Mixed lymphocyte cultures with inbred individuals: an approach to MLC typing.

Authors:  F Jorgensen; L U Lamm; F Kissmeyer-Nielsen
Journal:  Tissue Antigens       Date:  1973

3.  Stimulatory and cytotoxic activity on human adult and fetal lymphocytes by heterologous antihuman fetal lymphocyte sera.

Authors:  O Turunen; C Lundqvist; M Julin; G Holmlund; A Tiilikainen; A de la Chapelle
Journal:  Transplantation       Date:  1979-05       Impact factor: 4.939

Review 4.  HLA genetic heterogeneity in diabetes mellitus.

Authors:  A G Cudworth; H Festenstein
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

5.  An islet cell antibody negative form of insulin-dependent diabetes mellitus (IDD) associated with HLA antigens A9 and Bw16.

Authors:  A Mustonen; J Ilonen; H K Akerblom; A Tiilikainen
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

6.  The genetics of the glucose intolerance disorders.

Authors:  J I Rotter; D L Rimoin
Journal:  Am J Med       Date:  1981-01       Impact factor: 4.965

7.  Genetic patterns in diabetes mellitus.

Authors:  R Tattersall; D Pyke; J Nerup
Journal:  Hum Pathol       Date:  1980-05       Impact factor: 3.466

8.  HLA genetics of insulin-dependent juvenile-onset diabetes mellitus in northern Finland.

Authors:  J Ilonen; E Herva; A Tiilikainen; H K Akerblom; A Mustonen; T Koivukangas; K Kouvalainen
Journal:  Tissue Antigens       Date:  1980-04
  8 in total
  3 in total

1.  An analysis of epidemiological data in HLA-typed diabetic children.

Authors:  A Mustonen; J Ilonen; A Tiilikainen; M Kataja; H K Akerblom
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

2.  A 'new' DR4 associated D specificity 'JA' in type 1 (insulin-dependent) diabetes: A9, Bw16, DJA, DR4 haplotype.

Authors:  A Mustonen; J Ilonen; H M Surcel; H K Akerblom
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

3.  Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes.

Authors:  Kati Lipponen; Zsofia Gombos; Minna Kiviniemi; Heli Siljander; Johanna Lempainen; Robert Hermann; Riitta Veijola; Olli Simell; Mikael Knip; Jorma Ilonen
Journal:  Diabetes       Date:  2010-08-25       Impact factor: 9.461

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.